ACR适用性标准:弥漫性肺疾病2026更新
本文为美国放射学会更新的弥漫性肺疾病影像适用性标准,覆盖疑似DLD的初始影像、确诊DLD急性加重或急性恶化的初始影像、以及无急性恶化的确诊DLD监测三个临床场景。方法上由多学科专家小组每年审查,采用GRADE评估证据,并用RAND/UCLA适用性方法确定影像与治疗操作的适宜性。核心目的是通过多学科讨论中的影像作用,为DLD诊断和监测提供循证指南。
要点
- 多学科讨论是当前DLD诊断和监测的标准,影像在其中起核心作用。
- 适用性标准分为初始疑似、急性恶化、无急性恶化的监测三个临床场景。
- 证据缺乏或不确定时以专家意见作为形成推荐的主要证据来源。
核心结论
- 本文件旨在为弥漫性肺疾病建立影像评估指南,包括疑似DLD初始影像、确诊DLD急性加重或急性恶化的初始影像、以及无急性恶化的确诊DLD监测。
研究设计与样本
- 美国放射学会适用性标准由多学科专家小组每年审查,基于同行评议期刊文献进行系统分析。
- 采用GRADE分级方法评价证据,并采用RAND/UCLA适用性方法确定特定临床场景下影像操作的适宜性。
- 弥漫性肺疾病可累及肺实质并可能伴有胸部多腔室受累,包含数百种临床综合征和病理类型。
临床应用与阅片要点
- 在缺乏或文献证据不确定时专家意见可作为形成推荐的主要证据来源。
- 影像在弥漫性肺疾病多学科讨论中发挥核心作用,应纳入日常诊断和监测流程。
局限性
- 部分情况下同行评议文献缺乏或不确定,此时主要依赖专家意见形成推荐。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Diffuse lung diseases (DLD) also referred to as diffuse parenchymal lung diseases or interstitial lung diseases encompass diverse disorders affecting the lung parenchyma with possible multicompartment involvement in the chest. DLD include several hundred established clinical syndromes and pathologies, with a variety of possible etiologies. Imaging plays a central role during multidisciplinary discussion, which constitutes the current standard for diagnosis and monitoring of DLD. This document aims to establish guidelines for evaluation of diffuse lung diseases for 1) initial imaging of suspected diffuse lung disease, 2) initial imaging of suspected acute exacerbation or acute deterioration in cases of confirmed diffuse lung disease, and 3) surveillance of confirmed diffuse lung disease without acute deterioration. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.
引用
- Chelala, Walker, Little, et al. ACR Appropriateness Criteria® Diffuse Lung Disease: 2026 Update. J Am Coll Radiol. 2026. PMID: 42578903. doi:10.1016/j.jacr.2026.07.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。